跳至主要内容
临床试验/CTRI/2025/10/095833
CTRI/2025/10/095833尚未招募1 期

“A PROSEPCTIVE CLINICAL STUDY TO ASSESS THE EFFECTIVENESS OF CONSTITUTIONAL HOMEOPATHIC MEDICINE IN CASES OF ECZEMA BETWEEN THE AGE OF 15-55 YEARS OF BOTH SEX BY USING THE ECZEMA AREA AND SEVERITY INDEX (EASI) SCALE”

SAINATH HOSPITAL1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月22日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Change in Eczema Area and Severity Index score from baseline to the end of the treatment.

研究概览

简要总结

Eczema is a chronic, relapsing inflammatory skin disorder characterized by itching, redness, dryness, and lichenification, often causing considerable psychosocial distress. Conventional treatments such as corticosteroids and immunosuppressants may provide temporary relief but are associated with side effects and frequent relapses. Homeopathy, with its constitutional and holistic approach, aims to treat the individual as a whole, addressing not only the skin but also the mental and emotional spheres. This study seeks to scientifically evaluate the effectiveness of constitutional homeopathic medicines in eczema cases using the Eczema Area and Severity Index (EASI) as the assessment tool.

This prospective, clinical, interventional study will include 50 patients of both sexes aged 15–55 years, diagnosed with eczema. Case-taking will be performed as per Hahnemann’s guidelines (Organon aphorisms 83–104), followed by repertorization and prescription of individualized constitutional remedies. Patients will be followed up every 15 days for 12 months, and progress will be measured using the EASI scale.

The study aims to provide evidence on the role of constitutional homeopathy in improving the severity and extent of eczema, potentially offering a safe, effective, and holistic alternative to conventional therapy. By using a standardized scoring system, this research intends to bridge traditional homeopathic practice with objective clinical assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • clinically diagnosed patients eczema based on EASI scale , both sex , between age of 15-55 , willing and able to give written informed consent.

排除标准

  • Pt suffering from another skin diseases like psoriasis , lichen planus , tinea , bacterial and viral infections Autoimmune markers positive — suggests lupus or other autoimmune skin conditions.
  • Presence of systemic symptoms (like fever, weight loss) — might indicate more serious conditions.
  • Participants in another intervational study within the last 3 months.
  • Presence of serious comorbidities (eg.
  • Malignancy , uncontrolled diabetes , severe cardiac disease.
  • pregnant or lactating women.

结局指标

主要结局

Change in Eczema Area and Severity Index score from baseline to the end of the treatment.

时间窗: Change in Eczema Area and Severity Index score from baseline to the end of the treatment. | This measures the effectiveness of constitutional homeopathic medicine in reducing eczema severity.

This measures the effectiveness of constitutional homeopathic medicine in reducing eczema severity.

时间窗: Change in Eczema Area and Severity Index score from baseline to the end of the treatment. | This measures the effectiveness of constitutional homeopathic medicine in reducing eczema severity.

次要结局

  • 1. Improvement in patient-reported symptoms using a Visual Analog Scale(2. Improvement in quality of life assessed by Dermatology Life Quality Index or similar questionnaire.)

研究者

发起方
SAINATH HOSPITAL
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

KANZARIYA NAVIN BHUPATBHAI

RAJKOT HOMEOPATHIC MEDICAL COLEGE

研究点 (1)

Loading locations...

相似试验